Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled

BACKGROUND: In the present study, we explored the risk factors for relapse after discontinuation of biologic disease-modifying antirheumatic drug (bDMARD) therapy in patients with rheumatoid arthritis (RA) whose ultrasound power Doppler (PD) synovitis activity and clinical disease activity were well...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Arthritis Res Ther
Main Authors: Kawashiri, Shin-ya, Fujikawa, Keita, Nishino, Ayako, Okada, Akitomo, Aramaki, Toshiyuki, Shimizu, Toshimasa, Umeda, Masataka, Fukui, Shoichi, Suzuki, Takahisa, Koga, Tomohiro, Iwamoto, Naoki, Ichinose, Kunihiro, Tamai, Mami, Mizokami, Akinari, Nakamura, Hideki, Origuchi, Tomoki, Ueki, Yukitaka, Aoyagi, Kiyoshi, Maeda, Takahiro, Kawakami, Atsushi
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2017
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445491/
https://ncbi.nlm.nih.gov/pubmed/28545509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1320-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים